跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ESCOPRO POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
ESCOPRO POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL
Approved
THERAPEUTIC
ESCOPRO POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL
IMMACULE LIFESCIENCES PRIVATE LIMITED
🇸🇬 Health Sciences Authority
Approval Date
May 8, 2024
Approval ID
34b958bfb8f87fe6
Company
IMMACULE LIFESCIENCES PRIVATE LIMITED
Type
Therapeutic
Approval Details
Approval Id
34b958bfb8f87fe6
Drug Name
ESCOPRO POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL
Product Name
ESCOPRO POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL
Approval Number
SIN17003P
Approval Date
2024-05-08
Registrant
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
A02BC05
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE
40mg/vial
ESOMEPRAZOLE SODIUM EQUIVALENT TO ESOMEPRAZOLE
40mg/vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 8, 2024
Approval ID
34b958bfb8f87fe6
Type
Therapeutic
Back to HSA Approvals
